MedTrace Logo

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)

NCT00459693 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-09-10

No results posted yet for this study

Summary

The purpose of this protocol is to measure a receptor in the brain using positron emission tomography (PET) that is involved in inflammation.

Conditions

  • HIV-Dementia
  • HIV-Associated Cognitive Motor Complex
  • AIDS Encephalopathy
  • AIDS Dementia Complex
  • AIDS-Related Dementia Complex
  • HIV Infections
  • Healthy

Interventions

DRUG

[11C]PBR28

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    lead NIH

Principal Investigators

  • William C Kreisl, M.D. · National Institute of Mental Health (NIMH)

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-09
Primary Completion
2014-04-06
Completion
2014-04-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00459693 on ClinicalTrials.gov